Charles E. Dean

The Skeptical Professional's Guide to Psychiatry

On the Risks and Benefits of Antipsychotics, Antidepressants, Psychiatric Diagnoses, and Neuromania

• Broschiertes Buch

Produktbeschreibung

This text critically examines the shortcomings of psychiatry; the flawed development of the diagnostic system, including the DSM-5; and the failure to advance the effectiveness of antipsychotics and antidepressants. Starting with an overview of the evolution of psychiatry, Dean explores the creation, use, and misuse of medications, a process largely driven by drug companies. Other chapters describe the benefits and risks of medications, the problems associated with rational prescribing, and the embrace of so-called novel therapies including hallucinogenic drugs and opioids. Chapters end with a set of clinical notes that provide specific recommendations to clinicians, families, patients, and other providers, emphasizing the risks and benefits of treatment with medications but also stressing alternative approaches. This book will challenge clinicians to think critically about the DSM-5 and the current systems of diagnosis and treatment of mental illnesses in the hopes of ultimately improving the lives of people with mental illnesses.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Routledge
• Seitenzahl: 350
• Erscheinungstermin: 23. November 2020
• Englisch
• Abmessung: 229mm x 152mm x 19mm
• Gewicht: 508g
• ISBN-13: 9780367469207
• ISBN-10: 0367469200
• Artikelnr.: 60012791

Autorenporträt

Charles E. Dean, M.D., has 47 years of clinical, educational, and research experience. He has taught psychopharmacology and clinical neuroscience at the Minneapolis VA Medical Center and the University of Minnesota.

Inhaltsangabe

List of Abbreviations; Permissions; Introduction; Chapter 1. The Biological
Revolution in Psychiatry: An Overview of the Dark Ages; Chapter 2. The
Biological Revolution: The Middle Years and the Rise of Psychopharmacology;
Chapter 3. Has the Biological Revolution Delivered? A Focus on
Antipsychotics; Chapter 4. Antipsychotics and the Metabolic Syndrome,
Cardiovascular Disease, and Mortality; Chapter 5. Antipsychotics and
Mortality in the Elderly with Dementia; Chapter 6. Psychotropic and
Antipsychotic Polypharmacy: Common Practice, Good Medicine?; Chapter 7. The
Neurologic Consequences of Antipsychotics: From Parkinsonism to Tardive
Dyskinesia; Chapter 8. Antidepressants and Depression: Background and
Biology; Chapter 9. Antidepressants: Do They Work? If So, When, How Often,
and at What Costs?; Chapter 10. Antidepressants and Adverse Events: Falls
and Fractures, Vascular Events, Risks in Pregnancy, and Abnormal Movements;
Chapter 11. Treatment-Resistant Depression: Combining and Switching
Antidepressants, Adding Antipsychotics, and On to Neurotherapeutics;
Chapter 12. Desperately Treating Depression: On Psychotogenic and
Hallucinogenic Drugs, Anti-Inflammatories, Antidiabetics, Hyperthermia, and
Opioids; Chapter 13. Psychiatric Diagnoses: The DSM and the Roots of
Failure; Chapter 14. Fear and Loathing at the APA: The DSM-5, The Brain
Mapping Quartet, and the Future of Mental Illness; Index.